SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-23-011531
Filing Date
2023-06-28
Accepted
2023-06-28 17:18:54
Documents
14
Period of Report
2023-06-27
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K akya-20230627x8k.htm   iXBRL 8-K 43813
2 EX-10.1 akya-20230627xex10d1.htm EX-10.1 61226
  Complete submission text file 0001558370-23-011531.txt   329993

Data Files

Seq Description Document Type Size
3 EX-101.SCH akya-20230627.xsd EX-101.SCH 3250
4 EX-101.LAB akya-20230627_lab.xml EX-101.LAB 632
5 EX-101.PRE akya-20230627_pre.xml EX-101.PRE 10801
8 EXTRACTED XBRL INSTANCE DOCUMENT akya-20230627x8k_htm.xml XML 5042
Mailing Address 100 CAMPUS DRIVE 6TH FLOOR MARLBOROUGH MA 01762
Business Address 100 CAMPUS DRIVE 6TH FLOOR MARLBOROUGH MA 01762 855.896.8401
Akoya Biosciences, Inc. (Filer) CIK: 0001711933 (see all company filings)

IRS No.: 475586242 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40344 | Film No.: 231053195
SIC: 3826 Laboratory Analytical Instruments